Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:47 PM
Ignite Modification Date:
2025-12-24 @ 2:47 PM
NCT ID:
NCT03420859
Eligibility Criteria:
Inclusion Criteria:
* First, second or third IVF stimulation cycle at the involved clinic.
* BMI\<35.
* Written informed consent.
* 18-42 years old
Exclusion Criteria:
* HIV, Hepatitis B or C positivity.
* Intrauterine malformations (Vaginal ultrasound)
* Hysterosalpinx
* Known severe renal or hepatic impairment.
* HPV CIN 2 or higher.
* Patients treated with vitamin K antagonists (warfarin)
* Known or suspected hypersensitivity to clindamycin or any other antibiotic.
* Myastenia Gravis
* Former or current inflammatory bowel disease, including Mb. Crohn and Colitis ulcerosa
* Any uncontrolled concomitant disease (e.g. uncontrolled diabetes, uncontrolled hypertension etc.)
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
42 Years
Study:
NCT03420859
Study Brief:
Protocol Section:
NCT03420859